TY  - GEN
AU  - Rossi,Giulio
AU  - Cavazza,Alberto
AU  - Marchioni,Alessandro
AU  - Longo,Lucia
AU  - Migaldi,Mario
AU  - Sartori,Giuliana
AU  - Bigiani,Nazzarena
AU  - Schirosi,Laura
AU  - Casali,Christian
AU  - Morandi,Uliano
AU  - Facciolongo,Nicola
AU  - Maiorana,Antonio
AU  - Bavieri,Mario
AU  - Fabbri,Leonardo M
AU  - Brambilla,Elisabeth
TI  - Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung
SN  - 0732-183X
PY  - 2006///0213
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carboplatin
KW  - administration & dosage
KW  - Carcinoma, Large Cell
KW  - drug therapy
KW  - Carcinoma, Neuroendocrine
KW  - Carcinoma, Small Cell
KW  - Cisplatin
KW  - DNA Mutational Analysis
KW  - Deoxycytidine
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunohistochemistry
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Neoplasm Staging
KW  - Paclitaxel
KW  - Polymerase Chain Reaction
KW  - Proto-Oncogene Proteins c-kit
KW  - biosynthesis
KW  - Proto-Oncogene Proteins c-met
KW  - Receptor Protein-Tyrosine Kinases
KW  - Receptor, Platelet-Derived Growth Factor alpha
KW  - Receptor, Platelet-Derived Growth Factor beta
KW  - Survival Analysis
KW  - Survival Rate
KW  - Treatment Outcome
KW  - Gemcitabine
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2005.02.8233
ER  -